Abstract:Background Acute Respiratory Distress Syndrome (ARDS) involves extensive pulmonary vascular endothelial injury. Mitochondrial damage plays a critical role in this endothelial injury. While mesenchymal stem cells (MSCs) are being explored as a cellular therapy for ARDS, their role in repairing mitochondrial damage in endothelial cells remains unclear. This study investigates the potential of MSCs to repair mitochondrial damage in ARDS lung endothelial cells through mitochondrial transfer and elucidates the underlying mechanisms. Methods This study established ARDS mouse models and cellular models of mitochondrial damage in pulmonary endothelial cells. Initially, we observed the ability and mechanisms of MSCs to transfer mitochondria to lung endothelial cells both in vivo and in vitro. Subsequently, we investigated how this mitochondrial transfer by MSCs affects the repair of mitochondrial and endothelial damage, as well as its impact on vascular regeneration in ARDS. Finally, we elucidated the mechanisms by which MSC-mediated mitochondrial transfer promotes vascular regeneration in ARDS. Various cell biology techniques, including flow cytometry, immunofluorescence staining, and confocal microscopy, were utilized for experimental observations. Results MSCs used tunneling nanotubes (TNTs) to transfer mitochondria to pulmonary endothelial cells. The endothelial cells internalized these mitochondria through dynamin-dependent clathrin-mediated endocytosis. The mitochondrial transfer increased mitochondrial complex I expression, reduced ROS production and apoptosis, and promoted cell proliferation in endothelial cells. The reparative effects of MSCs diminished when their mitochondrial transfer ability was inhibited. MSC-mediated mitochondrial transfer activated the tricarboxylic acid (TCA) cycle and citrate-dependent fatty acid synthesis in endothelial cells, leading to the release of pro-angiogenic factors and promoting vascular regeneration. Inhibiting TCA or fatty acid synthesis in endothelial cells significantly reduced MSC-promoted vascular regeneration. Conclusion MSCs transfer mitochondria to ARDS lung endothelial cells, activating the TCA cycle and fatty acid synthesis, which promotes endothelial cell proliferation and the release of pro-angiogenic factors, thereby enhancing vascular regeneration. These findings offer a promising therapeutic approach for repairing mitochondrial damage and promoting vascular regeneration in ARDS.

Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS

MSC-Mediated Mitochondrial Transfer Promotes Metabolic Reprogramming in Endothelial Cells and Vascular Regeneration in ARDS

Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS

Abstract PR566

TFAM-Mediated mitochondrial transfer of MSCs improved the permeability barrier in sepsis-associated acute lung injury

AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages

Mesenchymal Stem Cell–Derived Extracellular Vesicles Alleviate Acute Lung Injury Via Transfer of Mir-27A-3p*

Studies on the Effects of Bone Marrow Stem Cells on Mitochondrial Function and the Alleviation of ARDS

Differential Effects of Extracellular Vesicles from Aging and Young Mesenchymal Stem Cells in Acute Lung Injury

Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung

The Effects of the Pneumonia Lung Microenvironment on MSC Function

Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in Klebsiella-mediated acute respiratory distress syndrome

Therapeutic Effects of Mesenchymal Stromal Cells Require Mitochondrial Transfer and Quality Control

Adipose-Derived Mesenchymal Stem Cells Ameliorating Pseudomonas aeruginosa–induced Acute Lung Infection via Inhibition of NLRC4 Inflammasome

Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs

A Novel Mechanism of Mesenchymal Stromal Cell-Mediated Protection Against Sepsis: Restricting Inflammasome Activation in Macrophages by Increasing Mitophagy and Decreasing Mitochondrial ROS

Electrosprayed Mesenchymal Stromal Cell Extracellular Matrix Nanoparticles Accelerate Cellular Wound Healing and Reduce Gram-Negative Bacterial Growth

Adipose-Derived Mesenchymal Stem Cells Ameliorating <i>Pseudomonas aeruginosa</i>-induced Acute Lung Infection <i>via</i> Inhibition of NLRC4 Inflammasome

Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury

Identification and Modulation of Microenvironment is Crucial for Effective MSC Therapy in Acute Lung Injury.

Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway